Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.
Adrenergic beta-Antagonists
/ therapeutic use
Angiotensin Receptor Antagonists
/ therapeutic use
Angiotensin-Converting Enzyme Inhibitors
/ therapeutic use
Cardiac Resynchronization Therapy
Death, Sudden, Cardiac
/ prevention & control
Defibrillators, Implantable
Heart Failure
/ complications
Humans
Hyperkalemia
/ chemically induced
Mineralocorticoid Receptor Antagonists
/ adverse effects
Polymers
Practice Guidelines as Topic
Renal Insufficiency, Chronic
/ complications
Risk Assessment
Severity of Illness Index
Silicates
Stroke Volume
chronic kidney disease
heart failure with reduced ejection fraction
heart failure management
Journal
JACC. Heart failure
ISSN: 2213-1787
Titre abrégé: JACC Heart Fail
Pays: United States
ID NLM: 101598241
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
27
01
2019
accepted:
20
02
2019
entrez:
4
5
2019
pubmed:
3
5
2019
medline:
15
9
2020
Statut:
ppublish
Résumé
Large randomized clinical trials (RCT) supporting guidelines for the management of heart failure with reduced ejection fraction (HFrEF) have typically excluded patients with advanced chronic kidney disease (CKD). Patients with concomitant advanced CKD and HFrEF experience poor cardiovascular outcomes and mortality relative to either disease in isolation and have been shown to consistently receive lower rates of HFrEF guideline-directed medical therapy (GDMT). This review evaluated recent evidence for the use of GDMT in patients with HFrEF and advanced CKD approaching dialysis from RCTs and observational cohorts. The authors also discuss the limitations and challenges inherent in the evidence for GDMT in this population, and offer guidance to clinicians for proper clinical use and future research directions.
Identifiants
pubmed: 31047016
pii: S2213-1779(19)30152-0
doi: 10.1016/j.jchf.2019.02.009
pmc: PMC6501813
mid: NIHMS1524023
pii:
doi:
Substances chimiques
Adrenergic beta-Antagonists
0
Angiotensin Receptor Antagonists
0
Angiotensin-Converting Enzyme Inhibitors
0
Mineralocorticoid Receptor Antagonists
0
Polymers
0
Silicates
0
patiromer
1FQ2RY5YHH
sodium zirconium cyclosilicate
D652ZWF066
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
371-382Subventions
Organisme : NIA NIH HHS
ID : R01 AG045551
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK111952
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL125511
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL110312
Pays : United States
Informations de copyright
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Références
J Am Coll Cardiol. 2011 Aug 23;58(9):889-96
pubmed: 21851875
N Engl J Med. 1987 Jun 4;316(23):1429-35
pubmed: 2883575
J Am Coll Cardiol. 2014 Mar 11;63(9):853-71
pubmed: 24334210
Am J Cardiol. 1990 Oct 2;66(11):40D-44D; discussion 44D-45D
pubmed: 2220604
Eur J Heart Fail. 2017 May;19(5):615-623
pubmed: 28217978
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239
pubmed: 23747642
Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1401-1412
pubmed: 27354656
N Engl J Med. 2014 Sep 11;371(11):993-1004
pubmed: 25176015
Kidney Int. 2013 Sep;84(3):622-3
pubmed: 23989362
BMJ. 2017 Mar 9;356:j791
pubmed: 28279964
Circulation. 2009 Oct 20;120(16):1577-84
pubmed: 19805651
ESC Heart Fail. 2018 Jun;5(3):257-266
pubmed: 29369537
Am J Cardiovasc Drugs. 2016 Feb;16(1):19-31
pubmed: 26156040
Eur Heart J. 2014 Feb;35(7):455-69
pubmed: 24164864
Am Heart J. 2007 Jun;153(6):1064-73
pubmed: 17540211
Circ Heart Fail. 2013 Nov;6(6):1124-31
pubmed: 24141097
N Engl J Med. 2004 Aug 5;351(6):543-51
pubmed: 15295047
Kidney Int. 2011 Sep;80(6):572-86
pubmed: 21750584
Circulation. 2006 Feb 7;113(5):671-8
pubmed: 16461840
Int Urol Nephrol. 2016 Sep;48(9):1499-509
pubmed: 27193436
JAMA Cardiol. 2018 Mar 1;3(3):215-224
pubmed: 29322198
J Card Fail. 2011 Dec;17(12):993-1000
pubmed: 22123361
Kidney Int. 2017 Aug;92(2):297-305
pubmed: 28709600
Eur J Heart Fail. 2010 Jun;12(6):607-16
pubmed: 20354032
Eur J Heart Fail. 2015 Oct;17(10):1057-65
pubmed: 26459796
Eur J Heart Fail. 2016 Oct;18(10):1238-1243
pubmed: 27364182
J Am Soc Nephrol. 2007 Apr;18(4):1307-15
pubmed: 17344421
N Engl J Med. 1996 May 23;334(21):1349-55
pubmed: 8614419
N Engl J Med. 1999 Sep 2;341(10):709-17
pubmed: 10471456
Lancet. 2003 Sep 6;362(9386):759-66
pubmed: 13678868
Am J Nephrol. 2014;40(5):399-407
pubmed: 25401485
Eur Heart J. 2015 Sep 7;36(34):2318-26
pubmed: 26069212
JACC Heart Fail. 2014 Dec;2(6):623-9
pubmed: 25306452
Am J Kidney Dis. 2016 May;67(5):728-41
pubmed: 26597926
J Card Fail. 2009 May;15(4):310-8
pubmed: 19398079
Circulation. 2016 Sep 27;134(13):e282-93
pubmed: 27208050
Circ J. 2018 Feb 23;82(3):691-698
pubmed: 28883225
J Am Coll Cardiol. 2011 Sep 6;58(11):1152-61
pubmed: 21884954
JACC Heart Fail. 2018 Jun;6(6):489-498
pubmed: 29655829
Int J Cardiol. 2013 Jul 15;167(1):151-6
pubmed: 22257685
J Card Fail. 2008 Sep;14(7):539-46
pubmed: 18722318
Eur J Heart Fail. 2017 Dec;19(12):1606-1614
pubmed: 28371075
Am J Kidney Dis. 2014 Jul;64(1):32-9
pubmed: 24518128
J Am Coll Cardiol. 2012 Nov 13;60(20):2082-9
pubmed: 23083787
N Engl J Med. 2011 Jan 6;364(1):11-21
pubmed: 21073363
Am Heart J. 2016 Aug;178:28-36
pubmed: 27502849
J Am Heart Assoc. 2017 Dec 23;6(12):
pubmed: 29275368
Lancet. 1999 Jun 12;353(9169):2001-7
pubmed: 10376614
Am Heart J. 2018 Oct;204:163-173
pubmed: 30121018
Am J Cardiol. 2006 Aug 15;98(4):485-90
pubmed: 16893702
J Nephrol. 2011 Jan-Feb;24(1):41-9
pubmed: 20349421
Am J Cardiol. 2014 Jul 1;114(1):79-82
pubmed: 24846806
J Card Fail. 2006 Sep;12(7):499-506
pubmed: 16952782
Circ Heart Fail. 2012 May 1;5(3):309-14
pubmed: 22441773
J Card Fail. 2013 Mar;19(3):176-82
pubmed: 23482078
Arch Intern Med. 2000 Mar 13;160(5):685-93
pubmed: 10724055
J Am Coll Cardiol. 2013 Oct 22;62(17):1585-93
pubmed: 23810881
Am J Cardiol. 2010 Apr 15;105(8):1140-6
pubmed: 20381667